Similar Articles
1021 Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein
1022 Update in management of hepatocellular carcinoma in Eastern population
1023 Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma
1024 Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma
1025 Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma
1026 Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients
1027 Liver transplantation as a management of hepatocellular carcinoma
1028 Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
1029 Current systemic treatment of hepatocellular carcinoma: A review of the literature
1030 Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA